Coegin Pharma Information

We are a Swedish innovation company developing and commercializing advanced cosmetic technologies for hair and skin. Our flagship innovation, Follicopeptide®, is a patented, clinically developed peptide technology targeting hair thinning. It is currently being introduced globally through selected partners and our own brand VEXIENNE®. In parallel, we are developing NPP-4, a next-generation cosmetic peptide innovation designed to enhance skin tone without UV exposure or chemicals. With scalable in-house production, established intellectual property, and a flexible commercial model, we are positioned to bring differentiated, science-based products to the global cosmetics market. Our share is listed on NGM Growth Market and dual-listed on Börse Stuttgart.